Top Markets
Coin of the day
Sientra, Inc. Sientra, Inc.

Sientra, Inc.

SIEN
Clasificación en acciones #39617
Sientra, Inc. is a global medical aesthetics firm specializing in the... Sientra, Inc. is a global medical aesthetics firm specializing in the development and distribution of a diverse range of aesthetic medical solutions. Its core offerings encompass silicone gel implants, utilized for both breast enhancement and reconstructive surgeries, alongside breast tissue expanders and various scar management solutions. These products are marketed under prominent brands such as Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. Beyond breast-related items, the company's portfolio extends to include products for body sculpting, facial and nasal implants, and saline-filled sizers. Sientra caters to a broad clientele, including hospitals, surgical facilities, plastic surgeons, dermatologists, and other specialized medical practitioners across the United States and internationally. Established in 2003, the enterprise was initially known as Juliet Medical, Inc., before adopting the Sientra, Inc. designation in April 2007. Its corporate headquarters are situated in Santa Barbara, California.
Precio por acción
$0.072
Última sincronización: 2024-03-18
Capitalización bursátil
$415.08K
Cambio (1 día)
5.73%
Cambio (1 año)
0.00%
País
US
Comercio Sientra, Inc. (SIEN)

Categoría

Ganancias de Sientra, Inc. (SIEN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Sientra, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Sientra, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US